Heart-Lung machine at the scene: could it save more cardiac arrest victims?

NCT ID NCT07041086

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether using a heart-lung machine (ECMO) right at the scene of a cardiac arrest can improve survival and brain function. Researchers will compare how quickly ECMO can be started on-site versus in the hospital. The trial involves 100 adults who have a witnessed cardiac arrest and receive bystander CPR.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Extracorporeal membrane oxygenation (ECMO) - a machine that pumps blood outside the body to add oxygen and remove carbon dioxide
What this could lead to
If it works, this could show that starting ECMO at the scene of a cardiac arrest saves more lives and reduces brain damage compared to standard CPR alone.
What could go wrong
This is a small, early-stage feasibility study, not a large definitive trial. ECMO is complex and risky, and results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC ARREST, OUT-OF-HOSPITAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiac arrest Out-of-Hospital Cardiac Arrest sudden cardiac arrest

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Emergency Medical Services, Moravian-Silesian Region

    RECRUITING

    Ostrava, Moravian-Silesian Region, 700 30, Czechia

  • University Hospital Ostrava

    RECRUITING

    Ostrava, Moravian-Silesian Region, 70852, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.